Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. Assoc. Prof
Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. Assoc. Prof
Dr.
DUBLIN, Nov. 2, 2021 /PRNewswire/ -- The "Canada Biobanks Market, By Type (Population Based Biobanks, Disease Oriented Biobanks, Tissue Biobanks, Others), By Ownership, By Product, By Specimen Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo Canada biobanks market is bound to experience impressive growth with an anticipated CAGR in the forecast period, 2022-2026, on account of increased research and technological advancement in genomic studies
Researchers from the INCLIVA Health Research Institute, the Clinical Hospital of Valencia, and the University of Valencia (UV) have participated in a study, the results of which have just been published in Science, which paves the way for a better understanding of muscle injury. The work will enable, in the future, the application of interventions that accelerate its repair both in the physiological field, in sports performance, and probably also in the clinical field, in the frail or sarcopenic patient (loss of muscle mass and strength in older adults).
Our Need For Things Lab-Grown What was once something of the movies objects forming themselves in thin air is real now. Various things can be grown in a laboratory setting, some even on a large scale for commercial distribution. This technology could be a big part of the solution to establish sustainable societies
Stem cell research is one of the most innovative research methods being used in modern society. However, it is also not very well known in todays society
Did you know that every three minutes someone receives a diagnosis of a blood cancer? According to the National Foundation for Cancer Research, blood cancers account for nearly 10% of new cancer diagnoses in the United States annually. That means that approximately 178,520 people will receive a diagnosis this year most commonly with leukemia, lymphoma or myeloma
Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines.
Published: Oct. 21, 2021 at 6:38 AM PDT AMES, Iowa, Oct
I am very pleased to begin this weeks update with news that work just published from our Queen Mary University of London research centre could pave the way for truly personalised treatment for patients diagnosed with glioblastoma multiforme (GBM).
Recent Comments